Category: <span>Pharmaceutical Updates</span>

Home / Pharmaceutical Updates
Post

Newfound Effect of Cancer Drug May Expand its Use

NEW YORK, Feb. 10, 2017 /PRNewswire-USNewswire/ — A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body’s attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology...

Post

New guidelines outline how to handle back pain

If you have an achy back, you’ve got company. As many as 80 percent of adults will have back pain. Berta Axelrad, 76, has lived with chronic low back pain for most of her life. “The pain is just so, well, it’s terrible!” she said. She swears by exercise, yoga and walking. “It minimizes the...

Post

FDA approves Northbrook company's $89,000 muscular dystrophy drug

Liam McNicholas, 12, of Lindenhurst, talks with Meghan Kostyk, an advanced practice nurse, on Feb. 9, 2017, during his biannual visit to Lurie Children’s Hospital for a checkup. Liam has Duchenne muscular dystrophy, a condition which is treated by a drug from a Northbrook company that just received FDA approval. (Alyssa Pointer / Chicago Tribune)...

Post

Common weed could help fight deadly superbug, study finds

Cassandra Quave, an ethnobotanist at Emory University, in her lab with berries from the Brazilian peppertree.    The red berries of a weed found in the southern United States contain an compound that can disarm a deadly superbug, according to research published Friday. Researchers from Emory University and the University of Iowa found that extracts...

Post

Could depression be treated with Botox?

In the largest randomized, double-blind, placebo controlled study to date on the effect of OnabotulinumtoxinA (as known as Botox) on depression, researchers found that more than half of subjects suffering from moderate to severe depression showed a substantial improvement (greater than or equal to 50% of baseline) in their depressive symptoms as measured by the...

Post

New male contraceptive jab that works for TWO YEARS: One-off 'reversible vasectomy' injection had 100% success rate with no side effects

A male contraceptive jab more effective than the Pill has been found to prevent pregnancy for up to two years. Contraception options for men have not changed in a century, remaining limited to condoms or the more drastic decision to have a vasectomy. But an injection which blocks sperm from leaving the body is a new...

Post

WATCH: Former Cop With Parkinson's Tries Cannabis Treatment for First Time

Over the past couple of years, The Free Thought Project has reported on many amazing examples of medical cannabis helping people who suffer from debilitating conditions. Numerous videos exist of children’s seizures stopping almost instantly after a dose of cannabis oil. Adults with Parkinson’s disease can also experience this miracle, as Larry Smith demonstrated in...

Post

Novel oral glucose lowering drugs cut risks in T2DM

(HealthDay)—For patients with type 2 diabetes, novel oral glucose lowering drugs (GLDs) are associated with reduced risks of all-cause mortality, cardiovascular disease (CVD), and hypoglycemia, compared with insulin use, according to a study published online Jan. 24 in Diabetes, Obesity and Metabolism. Thomas Nyström, M.D., from Karolinska Institutet in Stockholm, and colleagues compared use of novel...

Post

Alternative theory on how aspirin may thwart cancer

Lab studies point to platelet action as key to anti-tumor effect Studies abound that point to a role for plain old aspirin in keeping deadly cancers at bay. While aspirin is not yet part of mainstream treatment for any cancer, it is recommended by the U.S. Preventive Services Task Force for certain adults to help...

Post

How to stop pain from serious burns using epigenetics

Spinal cord. The unpleasant sensation sparked by the nervous system when confronted with a harmful stimulus can be alleviated by blocking a genetic marker that switches off the activity of the neurons involved. Jose Vicente Torres Pérez, a Spanish researcher who works at Imperial College in London, has trialled this innovative pain relief therapy on...